Effect of HABIT-ILE on Visuo-spatial Attention of Children With Unilateral CP

NCT ID: NCT02946086

Last Updated: 2020-12-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the changes induced by HABIT-ILE in impairments, activity and participation of children with unilateral CP, as well as neuroplastic changes induced by the treatment. Visuospatial deficits will be investigated and the effect of prismatic adaptation will be measured.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to investigate the changes induced by HABIT-ILE at the 3 levels of the international classification of functioning and health (ICF) in children with unilateral CP, as well as neuroplastic changes induced by the treatment. Visuospatial deficits will be investigated and the effect of prismatic adaptation will be measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

motor skill learning, visuo-spatial attention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

prismatic adaptation

Including 8 hours of therapy with prismatic adaptation wearing prismatic goggles during bimanual intensive and locomotor intensive intervention (HABIT-ILE).

Group Type EXPERIMENTAL

HABIT-ILE with prismatic adaptation

Intervention Type BEHAVIORAL

Bimanual and locomotor intensive intervention for 90h including 8 hours of prismatic adaptation

sham goggles

Including 8 hours of therapy wearing "sham goggles" during bimanual intensive and locomotor intensive intervention (HABIT-ILE).

Group Type ACTIVE_COMPARATOR

HABIT-ILE without prismatic adaptation

Intervention Type BEHAVIORAL

Bimanual and locomotor intensive intervention for 90h including 8 hours of prismatic adaptation wearing sham goggles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HABIT-ILE with prismatic adaptation

Bimanual and locomotor intensive intervention for 90h including 8 hours of prismatic adaptation

Intervention Type BEHAVIORAL

HABIT-ILE without prismatic adaptation

Bimanual and locomotor intensive intervention for 90h including 8 hours of prismatic adaptation wearing sham goggles.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* unilateral CP
* minimal ability to pick an light object from a table
* age 5-18

Exclusion Criteria

* no active seizure
* no botox or orthopedic intervention in the 6 months preceding the study or during the study
Minimum Eligible Age

5 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yannick Bleyenheuft

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yannick Bleyenheuft, PhD

Role: PRINCIPAL_INVESTIGATOR

Institute of Neuroscience, Université catholique de Louvain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bleyenheuft Yannick

Brussels, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B403201316810

Identifier Type: -

Identifier Source: org_study_id